TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE4
Triple Negative Breast Cancer Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
- Status
- TERMINATED
- Phase
- PHASE2
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Taxotere/Temodar/Cisplatin Study in Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Mycobacterium w Plus Docetaxel for Hormone Refractory Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)
- Status
- TERMINATED
- Phase
- PHASE3